BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20466374)

  • 1. Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice.
    Ishihara Y; Ohmori K; Mizukawa M; Hasan AU; Noma T; Kohno M
    Atherosclerosis; 2010 Sep; 212(1):131-8. PubMed ID: 20466374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysyl oxidase inhibitor β-aminopropionitrile reduces body weight gain and improves the metabolic profile in diet-induced obesity in rats.
    Miana M; Galán M; Martínez-Martínez E; Varona S; Jurado-López R; Bausa-Miranda B; Antequera A; Luaces M; Martínez-González J; Rodríguez C; Cachofeiro V
    Dis Model Mech; 2015 Jun; 8(6):543-51. PubMed ID: 26035864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 modulates adipocyte differentiation.
    Liang X; Kanjanabuch T; Mao SL; Hao CM; Tang YW; Declerck PJ; Hasty AH; Wasserman DH; Fogo AB; Ma LJ
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E103-E113. PubMed ID: 16144810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tongqiaohuoxue decoction ameliorates obesity-induced inflammation and the prothrombotic state by regulating adiponectin and plasminogen activator inhibitor-1.
    Kim SH; Park HS; Hong MJ; Yoo JY; Lee H; Lee JA; Hur J; Kwon DY; Kim MS
    J Ethnopharmacol; 2016 Nov; 192():201-209. PubMed ID: 27404230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo.
    Cho Y; Lee H; Park HK; Choe EY; Wang HJ; Kim RH; Kim Y; Kang ES
    J Atheroscler Thromb; 2020 May; 27(5):429-440. PubMed ID: 31527323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs.
    Xu C; Fang D; Chen X; Xinyue L; Nie Y; Xie Y; Ma Y; Deng S; Zhang Z; Song X
    Eur J Pharmacol; 2015 Sep; 762():364-71. PubMed ID: 26057693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine, a calcium-channel blocker, attenuated glucose intolerance and white adipose tissue dysfunction in type 2 diabetic KK-A(y) mice.
    Iwai M; Kanno H; Inaba S; Senba I; Sone H; Nakaoka H; Horiuchi M
    Am J Hypertens; 2011 Feb; 24(2):169-74. PubMed ID: 20847723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice.
    Fu L; Isobe K; Zeng Q; Suzukawa K; Takekoshi K; Kawakami Y
    Eur J Pharmacol; 2008 Apr; 584(1):202-6. PubMed ID: 18304529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific evidence for traditional claim of anti-obesity activity of Tecomella undulata bark.
    Alvala R; Alvala M; Sama V; Dharmarajan S; Ullas JV; B MR
    J Ethnopharmacol; 2013 Jul; 148(2):441-8. PubMed ID: 23628454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pitavastatin-enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes.
    Saiki A; Miyashita Y; Shirai K
    J Atheroscler Thromb; 2006 Apr; 13(2):122. PubMed ID: 16733301
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes.
    Ozaki KI; Awazu M; Tamiya M; Iwasaki Y; Harada A; Kugisaki S; Tanimura S; Kohno M
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(8):E643-E651. PubMed ID: 26860984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose availability controls adipogenesis in mouse 3T3-L1 adipocytes via up-regulation of nicotinamide metabolism.
    Jackson RM; Griesel BA; Gurley JM; Szweda LI; Olson AL
    J Biol Chem; 2017 Nov; 292(45):18556-18564. PubMed ID: 28916720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α modulates statin effects on secretion and expression of MCP-1, PAI-1 and adiponectin in 3T3-L1 differentiated adipocytes.
    Lobo SM; Quinto BM; Oyama L; Nakamichi R; Ribeiro AB; Zanella MT; Dalboni MA; Batista MC
    Cytokine; 2012 Oct; 60(1):150-6. PubMed ID: 22658637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Carotene accumulation in 3T3-L1 adipocytes inhibits the elevation of reactive oxygen species and the suppression of genes related to insulin sensitivity induced by tumor necrosis factor-α.
    Kameji H; Mochizuki K; Miyoshi N; Goda T
    Nutrition; 2010; 26(11-12):1151-6. PubMed ID: 20097535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance.
    Kamon J; Yamauchi T; Muto S; Takekawa S; Ito Y; Hada Y; Ogawa W; Itai A; Kasuga M; Tobe K; Kadowaki T
    Biochem Biophys Res Commun; 2004 Oct; 323(1):242-8. PubMed ID: 15351728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin enhances adipocyte differentiation, adiponectin expression, and antioxidant response in 3T3-L1 cells.
    Lee OH; Seo DH; Park CS; Kim YC
    Biofactors; 2010; 36(6):459-67. PubMed ID: 20806284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetylcysteine attenuates TNF-alpha induced changes in secretion of interleukin-6, plasminogen activator inhibitor-1 and adiponectin from 3T3-L1 adipocytes.
    Araki S; Dobashi K; Kubo K; Yamamoto Y; Asayama K; Shirahata A
    Life Sci; 2006 Nov; 79(25):2405-12. PubMed ID: 16952378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
    Kim ED; Kim E; Lee JH; Hyun CK
    Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.